Lisa Walter
Stock Analyst at RBC Capital
(2.88)
# 1,747
Out of 4,981 analysts
3
Total ratings
100%
Success rate
35.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Maintains: Outperform | $45 → $41 | $18.87 | +117.33% | 1 | Aug 7, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Sector Perform | $17 → $19 | $24.85 | -23.54% | 1 | Aug 1, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Outperform | $28 | $13.35 | +109.74% | 1 | Jun 17, 2025 |
Viridian Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $41
Current: $18.87
Upside: +117.33%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Sector Perform
Price Target: $17 → $19
Current: $24.85
Upside: -23.54%
EyePoint Pharmaceuticals
Jun 17, 2025
Initiates: Outperform
Price Target: $28
Current: $13.35
Upside: +109.74%